Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97B |
| 2 |
Microsoft
MSFT
|
+$1.32B |
| 3 |
Amgen
AMGN
|
+$1.09B |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$443M |
| 5 |
TSMC
TSM
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$993M |
| 2 |
CERN
Cerner Corp
CERN
|
+$863M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$586M |
| 4 |
AT&T
T
|
+$373M |
| 5 |
COHR
Coherent Inc
COHR
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Healthcare | 9.3% |
| 3 | Financials | 8.52% |
| 4 | Consumer Discretionary | 7.65% |
| 5 | Industrials | 4.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVT
5426
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $243K | ﹤0.01% |
52,593
+34,916
| +198% | +$203K |
|
5427
ESS Tech
GWH
$21.1M
| $242K | ﹤0.01% |
5,732
-3,863
| -40% | -$271K |
|
5428
Passage Bio
PASG
$14.4M
| $242K | ﹤0.01% |
5,116
-2,261
| -31% | -$106K |
|
|
FUV
5429
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $242K | ﹤0.01% |
3,694
-415
| -10% | -$32.9K |
|
|
TCRR
5430
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $242K | ﹤0.01% |
83,466
-85,333
| -51% | -$211K |
|
|
GLHA
5431
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
| $242K | ﹤0.01% |
24,699
| – | – |
|
5432
PUT
Archer Daniels Midland
ADM
$37.6B
| $241K | ﹤0.01% |
+3,100
| New | +$271K |
|
5433
CALL
Arcturus Therapeutics
ARCT
$171M
| $241K | ﹤0.01% |
+15,300
| New | +$300K |
|
|
5434
PUT
Arcturus Therapeutics
ARCT
$171M
| $241K | ﹤0.01% |
+15,300
| New | +$300K |
|
5435
OraSure Technologies
OSUR
$286M
| $241K | ﹤0.01% |
89,081
-64,246
| -42% | -$320K |
|
5436
GeneDx Holdings
WGS
$2.01B
| $241K | ﹤0.01% |
5,778
+1,203
| +26% | +$81.6K |
|
5437
VanEck Social Sentiment ETF
BUZZ
$95.2M
| $240K | ﹤0.01% |
18,583
-4,305
| -19% | -$65.3K |
|
|
OCFT
5438
DELISTED
OneConnect Financial Technology
OCFT
| $240K | ﹤0.01% |
14,017
+11,794
| +531% | +$167K |
|
5439
Hydrofarm Holdings
HYFM
$10.2M
| $239K | ﹤0.01% |
6,885
+3,612
| +110% | +$294K |
|
5440
UFP Technologies
UFPT
$2.07B
| $239K | ﹤0.01% |
3,002
-170
| -5% | -$12.5K |
|
5441
Cosan
CSAN
$3.19B
| $238K | ﹤0.01% |
17,099
-249
| -1% | -$4.13K |
|
|
BLUA
5442
DELISTED
BlueRiver Acquisition Corp.
BLUA
| $238K | ﹤0.01% |
24,172
| – | – |
|
|
RUBY
5443
DELISTED
Rubius Therapeutics, Inc
RUBY
| $238K | ﹤0.01% |
278,908
-105,845
| -28% | -$178K |
|
5444
StealthGas
GASS
$329M
| $237K | ﹤0.01% |
+73,875
| New | +$206K |
|
5445
Nuveen Short-Term REIT ETF
NURE
$36M
| $237K | ﹤0.01% |
+7,363
| New | +$263K |
|
5446
BARK
BARK
$88.8M
| $236K | ﹤0.01% |
9,218
-6,040
| -40% | -$305K |
|
5447
Colony Bankcorp
CBAN
$465M
| $236K | ﹤0.01% |
15,618
-23,105
| -60% | -$385K |
|
|
CMCT
5448
Creative Media & Community Trust
CMCT
$11.8M
| $236K | ﹤0.01% |
1
-1
| -50% | -$177K |
|
5449
Riverview Bancorp
RVSB
$108M
| $236K | ﹤0.01% |
35,852
-5,408
| -13% | -$37.1K |
|
5450
Solid Biosciences
SLDB
$790M
| $236K | ﹤0.01% |
25,535
+2,041
| +9% | +$21.2K |
|
Similar funds
Goldman Sachs's Q2 2022 Portfolio in Review
As of Q2 2022, Goldman Sachs held 6,980 positions worth $400B, down 16% from $476B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q2 2022 filing shows 409 new, 2,565 increased, 2,533 reduced and 543 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M. The largest sale was Invesco QQQ Trust, an estimated $993M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- Goldman Sachs's largest Q2 2022 buy was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $2.97B increase.
- Goldman Sachs's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $993M.
- Goldman Sachs fully exited Cerner Corp in Q2 2022, selling an estimated $863M.
- Goldman Sachs's ten largest holdings make up 18% of its $400B portfolio in Q2 2022.
- Goldman Sachs opened 409 new positions and closed 543 in Q2 2022.
- Goldman Sachs's portfolio value fell 16% quarter-over-quarter to $400B.
Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.